In PRAD, genes and pathways enriched at the sites of TEAD peaks include actin filament organization, epithelial morphogenesis, and cell substrate adhesion, all consistent with an adenocarcinoma lineage (exemplified by Tacstd2). Here, TACSTD2 is linked to adenocarcinoma.